On April 21, 2017, Kamillosan launched its latest campaign with a new endorser at Discovery Primera. This was also the venue where Kamillosan launched its Speak Up advocacy – in the hopes of making the brand mean more to the market beyond just providing relief from sore throat.
While waiting for the event to start, guests were requested to participate in the Kamillosan video booth, and record their answers to the question, “How do you encourage people with the power of your voice?” These videos were then shown at the end of the program and uploaded on the brand’s official Facebook page, Kamillosan PH.
The actual event kicked off with a brief welcome and introduction from A. Menarini Philippines’ General Manager, Ninia Torres. This was followed by an overview on sore throat by Dra. Clarissa Fortuna, supported by a product discussion from the brand’s medical manager, Dr. Gabby Santos.
But the voice that got everyone speaking up was Kamillosan’s newest endorser – Sarah Geronimo. She charmed everyone in her grand entrance as she powerfully sang and captured hearts, as she always does. Sarah also shared her own singing journey which highlighted how she learned to be an inspiration and motivation to others by power of voice and positivity – making her the perfect fit for Kamillosan’s Speak Up campaign.
“The essence of our campaign is to really encourage people to speak up with the help of Kamillosan. Just like Sarah, we hope to inspire people to pursue their passion without any hindrance along the way, especially sore throat,” shared Patty Nuqui, Marketing Director of Kamillosan.
“We are truly proud and delighted to have this opportunity to not just introduce a product we support and believe in, but to have Kamillosan take the higher ground and mean more to people than just a product for sore throat,” A. Menarini Philippines’ General Manager, Ninia Torres, added.
The event ended on a high note, with some of the guests creating cheers that captured the essence of Kamillosan and the Speak Up campaign.
To know more about Kamillosan, visit www.kamillosan.ph and like Kamillosan PH on Facebook.
Kamillosan is available in all leading drugstores nationwide at Php428.00 SRP. A 15mL bottle of Kamillosan is good for 104 sprays.
ABOUT MENARINI PHILIPPINES, INC.
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 131 years, with nearly 17,000 employees in over 100 countries. Here in Asia-Pacific, Menarini is focused on becoming a leading provider of important, research based healthcare brands from around the world to improve the lives of people in the region. Menarini Asia-Pacific operates across the entire commercial value chain, from regulatory approval and product launch to lifecycle management with a diverse portfolio comprising proprietary and partnered brands in key therapeutic fields, including Dermatology, Primary Care, Allergy/Respiratory, Cardiovascular, Oncology/Specialty Care, Women’s and Men’s Health, and Consumer Health.
With more than 3,500 employees throughout Asia Pacific and with its go-to-market expertise, along with unique insights of the Asian markets, patients, and physicians, Menarini Asia-Pacific operates throughout the commercial value chain, bringing biopharmaceutical brands from R&D, through to manufacturing, regulatory approvals and commercialization. We manage a portfolio of proprietary healthcare brands as well as licensed products from biotech and multinational companies. Partnering is a critical component of Menarini’s business model.
As multinational pharmaceutical companies re-prioritize portfolios and others seek experienced, trusted partners to enter large and emerging markets, Menarini provides the option of a single reliable partner in the Asia Pacific markets.
Menarini Asia-Pacific, formerly Invida, was formed in 2005 by a powerful strategic partnership of Quintiles, the world’s leading pharmaceutical services organization; Temasek Holdings, one of the world’s largest investment companies, and Zuellig Group, the largest pharmaceutical distribution and supply chain management network in Asia Pacific.
On 11 November 2011, Italy based Menarini Group successfully bid and acquired Invida Group, a strategic move that is poised to allow both companies and its partners to have a stronger presence in the Asia Pacific region. With over 16,000 employees and with a turnover of more than 3 Billion Euro, Menarini is the largest Italian pharmaceutical group and ranks 16th in Europe out of 5,291 companies, and 38th company in the world out of 19,042 companies. The Menarini Group operates in more than 100 countries.
Following the acquisition of Invida and its affiliated companies by the Menarini Group, the Management decided to transform the Invida brand to Menarini Asia-Pacific and promote a unified global brand.
Accordingly, Invida Philippines, Inc., started its operations as a separate entity last August 1, 2005. It has changed its name to A. Menarini Philippines, Inc. effective on November 6, 2012. Menarini Philippines has nearly 500 employees, majority of which are sales representatives, catering to the needs of patients and physicians in the therapeutic fields of cardiology, gastroenterology, pain, infectious disease, allergy/respiratory, men’s health, women’s health, dermatology, endocrinology, oncology and consumer health. Its office address is at 4th Floor, W Building, 11th Avenue corner 28th Street, Bonifacio High Street, Bonifacio Global City, Taguig City.
A. Menarini Philippines is a wholly-owned subsidiary of A. Menarini Asia-Pacific Pte. Ltd., a corporation organized under the laws of Singapore.
Menarini Asia-Pacific now carries with it the history, relationships and strong track record with its global partners. 04/26/2017 (The Lifestyle Portal)
Follow Us on Instagram: @therunnerrocky
Follow Us on Twitter: @therunnerrocky
Like Us on Facebook: www.facebook.com/TheLifestylePortal
For queries, Email us: email@example.com